Verseau Therapeutics competitorsClear all

Verseau Therapeutics's top competitors include Boundless Bio, FoRx Therapeutics, Intrepida Bio and Curis.
Verseau Therapeutics
Verseau Therapeutics
Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases.
Boundless Bio
Boundless Bio
Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers.
FoRx Therapeutics
FoRx Therapeutics
FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer.
Intrepida Bio
Intrepida Bio
Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases.
Curis
Curis
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
Founding Date
Founding Date
2017
Founding Date
2019
Founding Date
2019
Founding Date
2019
Founding Date
2000
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Bedford, US HQ
Locations
San Diego, US HQ
Locations
Basel, CH HQ
Locations
San Diego, US HQ
Locations
Lexington, US HQ
Lexington, US
Employees
Employees
225% increase
Employees
343% increase
Employees
717% increase
Employees
N/A
Employees
3144% decrease
Twitter followers
Twitter followers
45
Twitter followers
145
Twitter followers
44
Twitter followers
N/A
Twitter followers
173
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
220477
Alexa Website Rank
N/A
Alexa Website Rank
537337
Alexa Website Rank
247371
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.6

Funding

Latest funding round
Latest funding round
$ 50m (over 1 year ago)
Latest funding round
$ 46.4m (over 1 year ago)
Latest funding round
$ 10.8m (9 months ago)
Latest funding round
$ 9.5m (over 1 year ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 50m
Total funding raised
$ 46.4m
Total funding raised
$ 10.8m
Total funding raised
$ 9.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Boundless Bio
HQ
San Diego, US
Employees
34↑ 3% increase

Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers.

View company
FoRx Therapeutics
HQ
Basel, CH
Employees
7↑ 17% increase

FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer.

View company
Intrepida Bio
HQ
San Diego, US

Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases.

View company
Curis
HQ
Lexington, US
Employees
31↓ 44% decrease

Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.

View company